Overview
Ali Ravanpay is a Neurosurgery provider practicing medicine in Seattle, Washington. He has been practicing medicine for over 17 years.
Dr. Ravanpay is highly rated in 1 condition, according to our data. His clinical expertise encompasses Dysembryoplastic Neuroepithelial Tumors (DNET), Oligodendroglioma, Glioma, and Gliomatosis Cerebri.
He is actively involved in clinical research, co-authoring 18 peer reviewed articles. Dr. Ravanpay is currently accepting new patients.
Graduate Year
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- POS
- PPO
- PPO
- EPO
- PPO
Locations
325 9th Ave, Seattle, WA 98104
908 Jefferson St, Seattle, WA 98104
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Association Of University Physicians
Richard Ellenbogen is a Neurosurgery provider practicing medicine in Seattle, Washington. Dr. Ellenbogen is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Syringobulbia, Chiari Malformation Type 2, Syringomyelia, Posterior Fossa Decompression, and Laminectomy. Dr. Ellenbogen is currently accepting new patients.
Spine Center At Harborview
Randall Chesnut is a Neurosurgery provider practicing medicine in Seattle, Washington. Dr. Chesnut is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Traumatic Brain Injury, Increased Intracranial Pressure, Subdural Hematoma, Craniectomy, and Gastrostomy. Dr. Chesnut is currently accepting new patients.
Dr. McDougall became certified as a neurosurgeon in 1993. He has focused his entire career on the treatment of stroke and cerebrovascular disease, and he was one of the first neurosurgeons in the country to receive fellowship training in endovascular techniques. Once Guglielmi detachable coils received FDA approval in 1995, he was the first neurosurgeon in North America to treat a patient with an intracranial aneurysm using this device. Since that time, he has been extensively involved in research to improve endovascular techniques including being the principal investigator on large, randomized, international studies. He is a past president of the Society of NeuroInterventional Surgeons, has published over two hundred papers in peer reviewed journals and been an invited lecturer on every continent except Antarctica. Dr. Mcdougall is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Brain Aneurysm, Arteriovenous Malformation, Pica, Extracranial-Intracranial Bypass Surgery, and Stent Placement. Dr. Mcdougall is board certified in American Board Of Neurological Surgery. Dr. Mcdougall is currently accepting new patients.
Frequently Asked Questions about Dr. Ali C. Ravanpay
How do I make an appointment with Dr. Ali C. Ravanpay?
You can book an appointment with Dr. Ali C. Ravanpay by calling their office at 206-520-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Ali C. Ravanpay a top-rated expert for Dysembryoplastic Neuroepithelial Tumors (DNET)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ali C. Ravanpay is classified as an Advanced expert for Dysembryoplastic Neuroepithelial Tumors (DNET), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Ali C. Ravanpay specialize in?
While Dr. Ali C. Ravanpay is a Neurosurgery, they have specific expertise in Dysembryoplastic Neuroepithelial Tumors (DNET), Oligodendroglioma, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurosurgery.
Does Dr. Ali C. Ravanpay participate in research or clinical trials?
Yes. Dr. Ali C. Ravanpay has published 18 articles and abstracts on conditions like Dysembryoplastic Neuroepithelial Tumors (DNET). You can view a list of Dr. Ali C. Ravanpay's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Ali C. Ravanpay accept my insurance?
Dr. Ali C. Ravanpay accepts most major insurance plans, including Group Health Cooperative and PacificSource. We recommend calling the office directly at 206-520-5000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Dysembryoplastic Neuroepithelial Tumors (DNET)
- Experienced
- AstrocytomaDr. Ravanpay isExperienced. Learn about Astrocytoma.
- Brain TumorDr. Ravanpay isExperienced. Learn about Brain Tumor.
- GlioblastomaDr. Ravanpay isExperienced. Learn about Glioblastoma.
- GliomaDr. Ravanpay isExperienced. Learn about Glioma.
- Gliomatosis CerebriDr. Ravanpay isExperienced. Learn about Gliomatosis Cerebri.
- MeningiomaDr. Ravanpay isExperienced. Learn about Meningioma.
- OligodendrogliomaDr. Ravanpay isExperienced. Learn about Oligodendroglioma.
- Subdural HematomaDr. Ravanpay isExperienced. Learn about Subdural Hematoma.
